SANTA MONICA, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by GoodRx, Inc. (Nasdaq: GDRX), please note the announcement has been revised to include information about Synjardy ® , Synjardy XR ® and Stiolto Respimat ® . Complete corrected text follows: GoodRx , Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, and Boehringer Ingelheim , a privately-owned, leading global biopharmaceutical company, today announced a new joint effort to...